Johnson & Johnson Moves Forward with IBD Treatment Despite Trial Setback
Johnson & Johnson is proceeding with its inflammatory bowel disease therapy, even though recent trials did not demonstrate a statistically significant benefit for patients.
Latest Medicine stories from Life.
Johnson & Johnson is proceeding with its inflammatory bowel disease therapy, even though recent trials did not demonstrate a statistically significant benefit for patients.
This editorial examines the collaboration between the U.S. government and Gavi, the Vaccine Alliance, focusing on their efforts to enhance immunization access in lower-income countries.
Ruben Rocha Moya, the governor of Sinaloa and a member of the Morena party, has stepped down following accusations of drug trafficking connections.
The ongoing war in the Middle East is intensifying the healthcare challenges faced by Sudan, a nation already grappling with severe medical shortages.
A recent discussion highlights medical students' views on the integration of preventive care education in their curriculum, revealing concerns about coherence in their training.
Andy Spray shares his remarkable story of battling cancer and the pivotal role running played in his recovery, culminating in his completion of the London Marathon.
Julia Vintarello is embarking on a new biotech venture aimed at addressing the commercial and regulatory hurdles in the production of customized medicines.
Recent research suggests that compounds found in ginger and turmeric may help combat antibiotic-resistant infections, particularly affecting vulnerable groups.
Following the tragic New Year’s Eve fire in Crans-Montana, Switzerland has issued invoices to the families of victims, raising questions about who is responsible for medical expenses.
Rúben Rocha Moya, the governor of Sinaloa, faces drug trafficking charges in the US, linked to the Sinaloa Cartel, which has been labeled a foreign terrorist organization.
Recent advancements in copper-based single-atom nanozymes may enhance precision in malignant tumor therapies while minimizing side effects.
The U.S. Department of Health and Human Services (HHS) is appealing a ruling that impacts vaccine policy, following a lawsuit by the American Association of Pediatrics.
A new method for synthesizing polyfunctionalized biaryls without the use of transition-metal catalysts has been introduced by researchers at the Institute of Science Tokyo.
A group of medical students emphasizes the importance of integrating nutrition into medical training, advocating for a shift toward preventive health education.
While modern medicine aims to improve health, it often overlooks the importance of patient comfort and emotional well-being, leading many to seek alternative options.
This editorial provides a timeline of significant events related to the Trump administration's operations targeting suspected drug traffickers in the Caribbean and Eastern Pacific.
The FDA commissioner highlights how real-time clinical trials could change the landscape of drug development by providing regulators with immediate data insights.
Industry leaders express significant worries regarding the implications of Trump's drug pricing plan, while Purdue Pharma's sentencing underscores persistent challenges in the pharmaceutical sector.
The capture of Flores Silva, a prominent associate of the late drug lord 'El Mencho', marks a notable step in Mexico's fight against organized crime.
A recent recommendation to limit hepatitis B vaccinations at birth to only those infants deemed at risk raises alarms about potential increases in infections among newborns.